Bausch & Lomb (BLCO) Common Equity (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Common Equity came in at $6.4 billion in Q2 2026, down 0.98% on a YoY basis from $6.5 billion in Q2 2025, and little changed quarter-over-quarter from $6.5 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Common Equity (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Common Equity for 6 consecutive years, with $6.4 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity fell 0.98% year-over-year to $6.4 billion; the trailing twelve-month figure through Jun 2026 stood at $6.4 billion (down 0.98% YoY), and the FY2025 full-year result was $6.5 billion, changed 0.38% from the prior year.
- Common Equity was little changed at $6.4 billion in Q2 2026 per BLCO's latest filing, from $6.5 billion in the prior quarter.
- Across five years, Common Equity topped out at $7.2 billion in Q1 2022 and bottomed at $6.4 billion in Q1 2025.
- Historically, Common Equity has averaged $6.7 billion across 5 years, with a median of $6.7 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Common Equity fell 28.51% in 2022, then rose 1.3% in 2023.
- Over 5 years, Common Equity stood at $7.1 billion in 2022, then fell by 2.55% to $6.9 billion in 2023, then decreased by 5.43% to $6.5 billion in 2024, then declined by 0.38% to $6.5 billion in 2025, then slipped by 1.15% to $6.4 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $6.4 billion, $6.5 billion, and $6.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 6.44 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.44 Bn |
| Mar 31, 2026 | 6.45 Bn |
| Dec 31, 2025 | 6.52 Bn |
| Sep 30, 2025 | 6.50 Bn |
| Jun 30, 2025 | 6.51 Bn |
| Mar 31, 2025 | 6.43 Bn |
| Dec 31, 2024 | 6.54 Bn |
| Sep 30, 2024 | 6.66 Bn |
| Jun 30, 2024 | 6.58 Bn |
| Mar 31, 2024 | 6.73 Bn |
| Dec 31, 2023 | 6.92 Bn |
| Sep 30, 2023 | 6.88 Bn |
| Jun 30, 2023 | 7.03 Bn |
| Mar 31, 2023 | 7.05 Bn |
| Dec 31, 2022 | 7.10 Bn |
| Sep 30, 2022 | 6.80 Bn |
| Jun 30, 2022 | 6.97 Bn |
| Mar 31, 2022 | 7.22 Bn |
| Dec 31, 2021 | 9.40 Bn |
| Sep 30, 2021 | 9.39 Bn |